A Study of Cardiovascular Events iN Diabetes - A Randomized 2x2 Factorial Study of Aspirin Versus Placebo, and of Omega-3 Fatty Acid Supplementation Versus Placebo, for Primary Prevention of Cardiovascular Events in People With Diabetes
Latest Information Update: 15 May 2024
At a glance
- Drugs Aspirin (Primary) ; Omega-3-acid ethyl esters (Primary)
- Indications Cardiovascular disorders
- Focus Adverse reactions; Therapeutic Use
- Acronyms ASCEND
- 01 May 2024 Results (n=7360 of sub study ASCEND-Eye ) assessing Effects of Omega-3 Fatty Acids on Diabetic Retinopathy published in the Ophthalmology
- 08 Apr 2022 Results (n=15427) assessing effects of aspirin on dementia and cognitive functions in diabetic patients published in the European Heart Journal
- 15 Nov 2021 Results (n=15427) assessing the effect of low dose aspirin on the risk of dementia and cognitive impairment in a pre-specified secondary analysis presented at the American Heart Association Scientific Sessions 2021